March 30, 2023 Comments Off on New patent for Incyte Corp drug OPZELURA Posted in: Patent Added Annual Drug Patent Expirations for OPZELURA Opzelura is a drug marketed by Incyte Corp and is included in one NDA. It is available from one supplier. There are eleven patents…
The post New patent for Incyte Corp drug OPZELURA appeared first on DrugPate…
March 30, 2023 Comments Off on New patent for Altathera Pharms drug SOTALOL HYDROCHLORIDE Posted in: Patent Added Annual Drug Patent Expirations for SOTALOL+HYDROCHLORIDE Sotalol Hydrochloride is a drug marketed by Altathera Pharms Llc, Apotex, Aurobindo Pharma Usa, Beximco Pharms Usa, Epic Pharma Inc, Impax Pharms, Mylan, Oxford…
The post New patent for Altathera…